Andrew Reardon - 10 Aug 2023 Form 4 Insider Report for LIGAND PHARMACEUTICALS INC (LGND)

Signature
/s/ Andrew Reardon
Issuer symbol
LGND
Transactions as of
10 Aug 2023
Net transactions value
-$61,651
Form type
4
Filing time
14 Aug 2023, 16:20:56 UTC
Previous filing
28 Mar 2023
Next filing
04 Jan 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LGND Common Stock Tax liability $61,651 -897 -5.5% $68.73 15,411 10 Aug 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld by the Issuer in payment of the tax liability arising in connection with the settlement of restricted stock units.